RYAN ARTHUR F
SEC Form 4 insider trading activity
RYAN ARTHUR F has filed 6 SEC Form 4 filings (49 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jul 7, 2026.
On the most recent filing, RYAN ARTHUR F is listed as Director at REGENERON PHARMACEUTICALS, INC. Inside the rolling window, RYAN ARTHUR F reported no open-market purchases and 5 open-market sales totaling $435K in REGN. The largest disclosed transaction in the window is a sale of 200 REGN shares on Jul 2, 2026, worth $130K.
Companies traded
Other insiders at REGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$435K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has RYAN ARTHUR F made?
RYAN ARTHUR F has filed 6 SEC Form 4 filings (49 transaction rows) across 1 company since 2026.
Which companies does RYAN ARTHUR F trade?
RYAN ARTHUR F has filed SEC Form 4 disclosures for 1 company, including REGN.
When was RYAN ARTHUR F's most recent SEC Form 4 filing?
RYAN ARTHUR F's most recent SEC Form 4 filing on Tracefour is dated Jul 7, 2026.
What is RYAN ARTHUR F's total buy and sell value in the current window?
Inside the rolling retention window, RYAN ARTHUR F bought $0 and sold $435K based on SEC Form 4 filings.
What was RYAN ARTHUR F's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 200 REGN shares on 2026-07-02, worth $130K, per SEC Form 4 filings.